And Mike Daniel pumps in fresh capital to AoFrio to speed growth plans.
Forecast second half ebit will be higher than last year, jeweller says.
Departing CEO Marko Bogoievski has led a remarkable period of achievement for MCo.
Follows $80,000 penalty from NZX Disciplinary Tribunal in October.
Covid has led to more online sales and consequently lower margins, company says.
Medicinal cannabis co inks $900,000 distributor deal.
Sales down on same period last year but a record total in 2021.
Company expects US FDA decision on Maxigesic tablets and IV over next six months.
Inflation and reopenings in the spotlight as post-GFC bull run slows.
But manager estimates full-year fees from CDC will be around half last year's level.
